Home Cart Sign in  
Chemical Structure| 2043-57-4 Chemical Structure| 2043-57-4

Structure of 2043-57-4

Chemical Structure| 2043-57-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 2043-57-4 ]

CAS No. :2043-57-4
Formula : C8H4F13I
M.W : 474.00
SMILES Code : ICCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
MDL No. :MFCD00039410
InChI Key :NVVZEKTVIXIUKW-UHFFFAOYSA-N
Pubchem ID :74888

Safety of [ 2043-57-4 ]

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H315-H318-H410
Precautionary Statements:P280-P301+P312+P330-P305+P351+P338+P310
Class:9
UN#:3082
Packing Group:

Computational Chemistry of [ 2043-57-4 ] Show Less

Physicochemical Properties

Num. heavy atoms 22
Num. arom. heavy atoms 0
Fraction Csp3 1.0
Num. rotatable bonds 7
Num. H-bond acceptors 13.0
Num. H-bond donors 0.0
Molar Refractivity 54.42
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

0.0 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

3.3
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

6.16
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

11.01
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

5.65
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

6.53
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

6.53

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-6.2
Solubility 0.000301 mg/ml ; 0.000000634 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Poorly soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-5.94
Solubility 0.00054 mg/ml ; 0.00000114 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-5.41
Solubility 0.00184 mg/ml ; 0.00000387 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

Low
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

Yes
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

Yes
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-4.82 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

1.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

1.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

3.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

3.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<2.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

3.46

Application In Synthesis of [ 2043-57-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 2043-57-4 ]

[ 2043-57-4 ] Synthesis Path-Downstream   1~8

  • 1
  • [ 2043-57-4 ]
  • [ 22916-47-8 ]
  • 3-[2-(2,4-dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-octyl)-3<i>H</i>-imidazol-1-ium; iodide [ No CAS ]
  • 2
  • [ 6086-21-1 ]
  • [ 2043-57-4 ]
  • 1-methyl-4-(1H,1H,2H,2H-perfluorooctyl)-1,2,4-triazolium iodide [ No CAS ]
  • 3
  • 1-iodo-1H,1H,2H,2H-perfluorohexadecane [ No CAS ]
  • [ 2043-55-2 ]
  • [ 2043-57-4 ]
  • [ 2043-53-0 ]
  • [ 2043-54-1 ]
  • [ 30046-31-2 ]
  • [ 60699-51-6 ]
  • [ 647-42-7 ]
  • [ 865-86-1 ]
  • [ 2043-47-2 ]
  • [ 39239-77-5 ]
  • [ 678-39-7 ]
YieldReaction ConditionsOperation in experiment
With water;silver nitrate; copper(II) sulfate; at 180℃;Gas phase;Conversion of starting material; The catalyst of Preparation Example 8 (20 g) was placed in a stainless-steel reaction tube having an inner diameter of 10 mm and length of 250 mm, and was heated to 180° C. with a heater. CF3CF2 (CF2CF2)pCH2CH2I (mixture having a molar ratio of constituents of p=1/p=2/p=3/p=4/p=5/p=6=1.0/9.3/2.7/1.1/0.48/0.17) and water were introduced into a vaporizer at a rate of 2.8 g/hr and 12 g/hr, respectively, and were vaporized. Air was introduced into the reaction tube as a carrier gas at a rate of 35 cc/min. The vaporized gases were carried to the catalyst in the above reaction tube by the air to cause a catalytic reaction on the catalyst. Reaction products were recovered with an ice trap and a dry ice/methanol trap provided at the outlet of the reaction tube. The GC analysis of the products revealed that the corresponding alcohols were formed at the degree of conversion of 91percent and selectivity of 91percent.
YieldReaction ConditionsOperation in experiment
Purification / work up; Mixture of 1-iodo-1H,1H,2H,2H-perfluoroalkanes, 250 g (Mixture 2, average MW=591), and isopropanol (5 wt. %) were charged in a 400-mL Inconell shaker tube and heated to 190 C. for 12 hours. Analyses were conducted according to Test Methods 1 and 2. The level of perfluorooctyl iodide had decreased from 320 to 14 mg/kg and the level of perfluorooctanoic acid decreased from 45 to 2 mg/kg. Example 7 Mixture of 1-iodo-1H,1H,2H,2H-perfluoroalkanes, 450 g (Mixture 2, average MW=591), and monomethoxy-polyethyleneglycol (MW=350, 0.75 wt. %) were charged in a 400-mL stainless steel shaker tube and heated to 195 C. for 4 hours. Analyses were conducted according to Test Methods 1 and 2. The level of perfluorooctyl iodide had decreased from 320 to 23 mg/kg and the level of perfluorooctanoic acid decreased from 45 to 12 mg/kg.
  • 5
  • [ 2043-57-4 ]
  • [ 89635-82-5 ]
  • [ 1334419-22-5 ]
YieldReaction ConditionsOperation in experiment
71% General procedure: Perfluoroalkylethyl iodide (1.0 mol equiv.) (3-5 mmol) and NaN3 (1.0-1.5 mol equiv.) were added to dry DMSO (4 mL), a magnetic stirring bead added, and the mixture stirred under argon in a bath at 65 C for 24 h then cooled to r.t. The methoxytriethylenoxy propargyl ether 21 (1.0 mol equiv.) added, followed by sodium ascorbate (0.1 mol equiv.) and CuSO4·5H2O (0.05 mol equiv.), and additional DMSO (2 mL). The mixture was again stirred under argon at elevated temperature for 48 h. The contents were cooled and diluted with water (50 mL). The product was then extracted into Et2O (3 × 20 mL), and the combined extracts washed in turn with brine (2 × 10 mL), H2O (2 × 10 mL) and again brine (10 mL), then dried and evaporated. The residue was chromatographed on silica gel and the product eluted with a gradient of Et2O/light petroleum and distilled or characterized directly as an oil.
  • 6
  • [ 58196-33-1 ]
  • [ 2043-57-4 ]
  • [ 1441382-67-7 ]
  • 7
  • [ 2043-57-4 ]
  • [ 68631-52-7 ]
  • 4-[2-(perfluorohexyl)ethyloxy]pyridine-2,6-dicarboxylic acid dethyl ester [ No CAS ]
YieldReaction ConditionsOperation in experiment
93% With silver carbonate; In toluene; at 120℃; for 72h;Inert atmosphere; A mixture of <strong>[68631-52-7]4-hydroxypyridine-2,6-dicarboxylic acid diethyl ester</strong> (2; 5.03 g, 21.0 mmol) and Ag2CO3 (6.56 g, 23.8 mmol) in anhydrous toluene (350 mL) was stirred at 120 C under N2 for 2 h. Then, 1-iodo-2-(perfluorohexyl)ethane (7.68 mL, 31.4 mmol) was added dropwise and the reaction mixture was stirred for 3 d at 120 C. Insoluble material was removed by filtration and washed with EtOAc (200 mL). The solvent was removed under reduced pressure and the crude product was purified by column chromatography (silica gel, CH2Cl2-EtOAc15:1; Rf = 0.33) to give 3 as a colorless solid; yield: 11.4 g (93%); mp 70 C. IR (ATR): 2916, 2849 (aliph C-H), 1716 (C=O), 1600, 1584 (arom C=C),1232, 1188 (C-O), 1143, 1118 (C-F), 1039 cm-1 (C-O). 1H NMR (500 MHz, CDCl3): delta = 7.79 (s, 2 H, PyH), 4.48 (q, 3J = 7.1 Hz, 4H, OCH2CH3), 4.45 (t, 3J = 6.5 Hz, 2 H, OCH2CH2), 2.71 (tFt, 3JH,F = 18.0Hz, 3J = 6.5 Hz, 2 H, OCH2CH2CF2), 1.45 (t, 3J = 7.1 Hz, 6 H, OCH2CH3). 13C NMR (125 MHz, CDCl3): delta = 165.9 (s, 4-PyC), 164.5 (s, PyCO2Et),150.5 (s, 2,6-PyC), 117.3 (tF, 2JC,F = 32.4 Hz, CH2CF2CF2)*, 114.1 (d, 3,5-PyC), 62.5 (t, OCH2CH3), 60.9 (t, OCH2CH2CF2), 31.0 [t(tF), 2JC,F = 21.8Hz, CH2CH2CF2], 14.2 (q, OCH2CH3). * Only visible in the HMBC spectrum. 19F NMR (470 MHz, CDCl3): delta = -80.8 (s, 3 F, CF3), -113.2 (s, 2 F,CH2CF2), -121.8 (s, 2 F, CH2CF2CF2), -122.8 (s, 2 F, CF2CF3), -123.5 (s, 2F, CF2CF2CF3), -126.1 (s, 2 F, CH2CF2CF2CF2). MS (EI): m/z = 586 [M + H]+, 585 [M]+?, 584 [M - H]+, 512 [M -CO2CH2CH3]+, 439 [M - C6H10O4]+.HRMS (EI): m/z [M]+? calcd for C19H16F13NO5: 585.0821; found:585.0820.
  • 8
  • [ 2043-57-4 ]
  • [ 78430-91-8 ]
  • 1-(4-ethenylbenzyl)-3-(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)-1H-imidazol-3-ium iodide [ No CAS ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 2043-57-4 ]

Fluorinated Building Blocks

Chemical Structure| 2043-55-2

A851203 [2043-55-2]

1,1,1,2,2,3,3,4,4-Nonafluoro-6-iodohexane

Similarity: 1.00

Chemical Structure| 355-43-1

A166643 [355-43-1]

1,1,1,2,2,3,3,4,4,5,5,6,6-Tridecafluoro-6-iodohexane

Similarity: 0.79

Chemical Structure| 461-17-6

A603313 [461-17-6]

1,1,1-Trifluoro-4-iodobutane

Similarity: 0.70

Chemical Structure| 647-42-7

A310731 [647-42-7]

3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctan-1-ol

Similarity: 0.66

Chemical Structure| 2043-47-2

A350747 [2043-47-2]

1H,1H,2H,2H-Nonafluoro-1-hexanol

Similarity: 0.66

Aliphatic Chain Hydrocarbons

Chemical Structure| 2043-55-2

A851203 [2043-55-2]

1,1,1,2,2,3,3,4,4-Nonafluoro-6-iodohexane

Similarity: 1.00

Chemical Structure| 355-43-1

A166643 [355-43-1]

1,1,1,2,2,3,3,4,4,5,5,6,6-Tridecafluoro-6-iodohexane

Similarity: 0.79

Chemical Structure| 461-17-6

A603313 [461-17-6]

1,1,1-Trifluoro-4-iodobutane

Similarity: 0.70

Chemical Structure| 647-42-7

A310731 [647-42-7]

3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctan-1-ol

Similarity: 0.66

Chemical Structure| 2043-47-2

A350747 [2043-47-2]

1H,1H,2H,2H-Nonafluoro-1-hexanol

Similarity: 0.66

Trifluoromethyls

Chemical Structure| 2043-55-2

A851203 [2043-55-2]

1,1,1,2,2,3,3,4,4-Nonafluoro-6-iodohexane

Similarity: 1.00

Chemical Structure| 355-43-1

A166643 [355-43-1]

1,1,1,2,2,3,3,4,4,5,5,6,6-Tridecafluoro-6-iodohexane

Similarity: 0.79

Chemical Structure| 461-17-6

A603313 [461-17-6]

1,1,1-Trifluoro-4-iodobutane

Similarity: 0.70

Chemical Structure| 647-42-7

A310731 [647-42-7]

3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctan-1-ol

Similarity: 0.66

Chemical Structure| 2043-47-2

A350747 [2043-47-2]

1H,1H,2H,2H-Nonafluoro-1-hexanol

Similarity: 0.66